Skip to Main Content

Advertisement

Umbrella Alt Text
header search
Search
Advanced Search
Skip Nav Destination

Imatinib Mesylate Is a Potent Inhibitor of the ABCG2 (BCRP) Transporter and Reverses Resistance to Topotecan and SN-38 in Vitro

Cancer Res (2004) 64 (7): 2333–2337.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
A Structure-Based View on ABC-Transporter Linked to Multidrug Resistance
  • Jiahui Huang
  • Gerhard F. Ecker
Molecules (2023) 28 (2): 495.
Identification and pharmacological modification of resistance mechanisms to protoporphyrin-mediated photodynamic therapy in human cutaneous squamous cell carcinoma cell lines
  • Nicole Schary
  • Ben Novak
  • Laura Kämper
  • Aisha Yousf
  • Hermann Lübbert
Photodiagnosis and Photodynamic Therapy (2022) 39: 103004.
Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators
  • Ingrid Fatima Zattoni
  • Letícia Carani Delabio
  • Julia de Paula Dutra
  • Diogo Henrique Kita
  • Gustavo Scheiffer
  • Marina Hembecker
  • Giovana da Silva Pereira
  • Vivian Rotuno Moure
  • Glaucio Valdameri
European Journal of Medicinal Chemistry (2022) 237: 114346.
FL118, acting as a ‘molecular glue degrader’, binds to, dephosphorylates and degrades the oncoprotein DDX5 (p68) to control c‐Myc, survivin and mutant Kras against colorectal and pancreatic cancer with high efficacy
  • Xiang Ling
  • Wenjie Wu
  • Ieman A. M. Aljahdali
  • Jianqun Liao
  • Sreevidya Santha
  • Christos Fountzilas
  • Patrick M. Boland
  • Fengzhi Li
Clinical and Translational Medicine (2022) 12 (5)
COVID-19 drugs: potential interaction with ATP-binding cassette transporters P-glycoprotein and breast cancer resistance protein
  • Jaeok Lee
  • Jihye Kim
  • Jiyeon Kang
  • Hwa Jeong Lee
Journal of Pharmaceutical Investigation (2022)
Infigratinib (BGJ 398), a Pan-FGFR Inhibitor, Targets P-Glycoprotein and Increases Chemotherapeutic-Induced Mortality of Multidrug-Resistant Tumor Cells
  • Sergei Boichuk
  • Pavel Dunaev
  • Ilshat Mustafin
  • Shinjit Mani
  • Kirill Syuzov
  • Elena Valeeva
  • Firuza Bikinieva
  • Aigul Galembikova
Biomedicines (2022) 10 (3): 601.
Updated chemical scaffolds of ABCG2 inhibitors and their structure-inhibition relationships for future development
  • Md Moinul
  • Sk Abdul Amin
  • Tarun Jha
  • Shovanlal Gayen
European Journal of Medicinal Chemistry (2022) 241: 114628.
Intracellular Autofluorescence as a New Biomarker for Cancer Stem Cells in Glioblastoma
  • Joana Vieira de Castro
  • Céline S. Gonçalves
  • Eduarda P. Martins
  • Irene Miranda-Lorenzo
  • Mariana T. Cerqueira
  • Adhemar Longatto-Filho
  • Afonso A. Pinto
  • Rui L. Reis
  • Nuno Sousa
  • Christopher Heeschen
  • Bruno M. Costa
Cancers (2021) 13 (4): 828.
Characteristics of 18F-FDG and 18F-FDOPA PET in an 8-year-old neutered male Yorkshire Terrier dog with glioma: long-term chemotherapy using hydroxyurea plus imatinib with prednisolone and immunoreactivity for PDGFR-β and LAT1
  • Taesik Yun
  • Yoonhoi Koo
  • Sanggu Kim
  • Wonguk Lee
  • Hakhyun Kim
  • Dongwoo Chang
  • Soochong Kim
  • Mhan-Pyo Yang
  • Byeong-Teck Kang
Veterinary Quarterly (2021) 41 (1): 163.
Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma
  • Fengzhi Li
  • Ieman A. M. Aljahdali
  • Renyuan Zhang
  • Kent L. Nastiuk
  • John J. Krolewski
  • Xiang Ling
Journal of Experimental & Clinical Cancer Research (2021) 40 (1)
Multi-factorial pharmacokinetic interactions: unraveling complexities in precision drug therapy
  • Baron Bechtold
  • John Clarke
Expert Opinion on Drug Metabolism & Toxicology (2021) 17 (4): 397.
Overcoming barriers in photodynamic therapy harnessing nano-formulation strategies
  • Jianlei Xie
  • Yingwei Wang
  • Wonseok Choi
  • Paramesh Jangili
  • Yanqi Ge
  • Yunjie Xu
  • Jianlong Kang
  • Liping Liu
  • Bin Zhang
  • Zhongjian Xie
  • Jun He
  • Ni Xie
  • Guohui Nie
  • Han Zhang
  • Jong Seung Kim
Chemical Society Reviews (2021) 50 (16): 9152.
Breast Cancer Resistance Protein: A Potential Therapeutic Target for Cancer
  • Sonali Mehendale-Munj
  • Shivangi Sawant
Current Drug Targets (2021) 22 (4): 420.
Double-Coated Poly(butyl Cyanoacrylate) Nanoparticles as a Potential Carrier for Overcoming P-Gp- and BCRP-Mediated Multidrug Resistance in Cancer Cells
  • Neeraj Kaushal
  • Zhe-Sheng Chen
  • Senshang Lin
Frontiers in Nanotechnology (2021) 3
Concurrent Imatinib Dosing With High-dose Methotrexate Leads to Acute Kidney Injury and Delayed Methotrexate Clearance in Pediatric Patients With Philadelphia Chromosome-positive B-Cell Acute Lymphoblastic Leukemia
  • Lauren Pommert
  • Nicole Liberio
  • John S. Ng
  • Tosha A. Egelund
  • Molly J. Siver
  • Howard M. Katzenstein
  • Michael J. Burke
Journal of Pediatric Hematology/Oncology (2021) 43 (2): e296.
Prospective Drug Candidates as Human Multidrug Transporter ABCG2 Inhibitors: an In Silico Drug Discovery Study
  • Mahmoud A. A. Ibrahim
  • Esraa A. A. Badr
  • Alaa H. M. Abdelrahman
  • Nahlah Makki Almansour
  • Ahmed M. Shawky
  • Gamal A. H. Mekhemer
  • Faris Alrumaihi
  • Mahmoud F. Moustafa
  • Mohamed A. M. Atia
Cell Biochemistry and Biophysics (2021) 79 (2): 189.
Enhanced proliferation inhibition and apoptosis in glioma cells elicited by combination of irinotecan and imatinib
  • Jiabin Lu
  • Yuhuai Hu
  • Renyun Qian
  • Yuqian Zhang
  • Xiaochun Yang
  • Peihua Luo
European Journal of Pharmacology (2020) 874: 173022.
Regulating Stem Cell-Related Genes Induces the Plastic Differentiation of Cancer Stem Cells to Treat Breast Cancer
  • Jing-Ying Zhang
  • Qian Luo
  • Jia-Rui Xu
  • Jing Bai
  • Li-Min Mu
  • Yan Yan
  • Jia-Lun Duan
  • Yi-Nuo Cui
  • Zhan-Bo Su
  • Ying Xie
  • Wan-Liang Lu
Molecular Therapy - Oncolytics (2020) 18: 396.
ABCG2 transports anticancer drugs via a closed-to-open switch
  • Benjamin J. Orlando
  • Maofu Liao
Nature Communications (2020) 11 (1)
Treatment-driven selection of chemoresistant Ewing sarcoma tumors with limited drug distribution
  • Helena Castillo-Ecija
  • Carles Monterrubio
  • Guillem Pascual-Pasto
  • Soledad Gomez-Gonzalez
  • Daniel J. Garcia-Dominguez
  • Lourdes Hontecillas-Prieto
  • Claudia Resa-Pares
  • Victor Burgueño
  • Sonia Paco
  • Nagore G. Olaciregui
  • Monica Vila-Ubach
  • Camilo Restrepo-Perdomo
  • Maria Cuadrado-Vilanova
  • Leire Balaguer-Lluna
  • Sara Perez-Jaume
  • Alicia Castañeda
  • Vicente Santa-Maria
  • Monica Roldan
  • Mariona Suñol
  • Enrique de Alava
  • Jaume Mora
  • Cinzia Lavarino
  • Angel M. Carcaboso
Journal of Controlled Release (2020) 324: 440.
Role of ATP-Binding Cassette Transporter Proteins in CNS Tumors: Resistance- Based Perspectives and Clinical Updates
  • M. Asif
  • M. Usman
  • Shahid Ayub
  • Sahar Farhat
  • Zilli Huma
  • Jawad Ahmed
  • Mohammad A. Kamal
  • Deema Hussein
  • Aneela Javed
  • Ishaq Khan
Current Pharmaceutical Design (2020) 26 (37): 4747.
Mutant Kras as a Biomarker Plays a Favorable Role in FL118-Induced Apoptosis, Reactive Oxygen Species (ROS) Production and Modulation of Survivin, Mcl-1 and XIAP in Human Bladder Cancer
  • Sreevidya Santha
  • Xiang Ling
  • Ieman A. M. Aljahdali
  • Sailee S. Rasam
  • Xue Wang
  • Jianqun Liao
  • Jue Wang
  • Christos Fountzilas
  • Qingyong Li
  • Jun Qu
  • Fengzhi Li
Cancers (2020) 12 (11): 3413.
Impact of Q141K on the Transport of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors by ABCG2
  • Yutaka Inoue
  • Takashi Morita
  • Mari Onozuka
  • Ken-ichi Saito
  • Kazumi Sano
  • Kazuhiko Hanada
  • Masami Kondo
  • Yoichi Nakamura
  • Tohru Kishino
  • Hiroshi Nakagawa
  • Yoji Ikegami
Cells (2019) 8 (7): 763.
Nonionic surfactants modulate the transport activity of ATP-binding cassette (ABC) transporters and solute carriers (SLC): Relevance to oral drug absorption
  • Ahmed A. Abdulhussein Al-Ali
  • Rasmus Blaaholm Nielsen
  • Bente Steffansen
  • René Holm
  • Carsten Uhd Nielsen
International Journal of Pharmaceutics (2019) 566: 410.
Cancer therapeutics using survivin BIRC5 as a target: what can we do after over two decades of study?
  • Fengzhi Li
  • Ieman Aljahdali
  • Xiang Ling
Journal of Experimental & Clinical Cancer Research (2019) 38 (1)
Metabolome Analysis Reveals Dermal Histamine Accumulation in Murine Dermatitis Provoked by Genetic Deletion of P-Glycoprotein and Breast Cancer Resistance Protein
  • Naoto Hashimoto
  • Noritaka Nakamichi
  • Hikari Nanmo
  • Kei-ichi Kimura
  • Yusuke Masuo
  • Yasuyuki Sakai
  • Alfred H. Schinkel
  • Shinichi Sato
  • Tomoyoshi Soga
  • Yukio Kato
Pharmaceutical Research (2019) 36 (11)
Challenges and Opportunities for Childhood Cancer Drug Development
  • Peter J. Houghton
  • Raushan T. Kurmasheva
  • Michael M. Gottesman
Pharmacological Reviews (2019) 71 (4): 671.
Cariprazine, A Dopamine D2/D3 Receptor Partial Agonist, Modulates ABCG2-Mediated Multidrug Resistance in Cancer
  • Noor Hussein
  • Charles Ashby
  • Haneen Amawi
  • Angelique Nyinawabera
  • Atul Vij
  • Vishwa Khare
  • Chandrabose Karthikeyan
  • Amit Tiwari
Cancers (2018) 10 (9): 308.
Co-delivery of doxorubicin and imatinib by pH sensitive cleavable PEGylated nanoliposomes with folate-mediated targeting to overcome multidrug resistance
  • Yan Chen
  • Yao Cheng
  • Pengxuan Zhao
  • Shasha Zhang
  • Minsi Li
  • Chuanchuan He
  • Xiaojuan Zhang
  • Tan Yang
  • Ruicong Yan
  • Peng Ye
  • Xiang Ma
  • Guangya Xiang
International Journal of Pharmaceutics (2018) 542 (1-2): 266.
Transcriptome analysis of ABCB1, ABCG2 and the BCL2/BAX ratio in refractory and relapsed canine lymphomas under treatment and rescue protocol
  • Sirintra Sirivisoot
  • Patharakrit Teewasutrakul
  • Anudep Rungsipipat
  • Sirikachorn Tangkawattana
  • Somporn Techangamsuwan
Acta Veterinaria (2018) 68 (1): 16.
Gene-by-Environment Interaction of Bcrp−/− and Methionine- and Choline-Deficient Diet–Induced Nonalcoholic Steatohepatitis Alters SN-38 Disposition
  • Erica L. Toth
  • Hui Li
  • Anika L. Dzierlenga
  • John D. Clarke
  • Anna Vildhede
  • Michael Goedken
  • Nathan J. Cherrington
Drug Metabolism and Disposition (2018) 46 (11): 1478.
Tyrosine kinase inhibitors enhanced the efficacy of conventional chemotherapeutic agent in multidrug resistant cancer cells
  • Shaocong Wu
  • Liwu Fu
Molecular Cancer (2018) 17 (1)
A Promising Microtubule Inhibitor Deoxypodophyllotoxin Exhibits Better Efficacy to Multidrug-Resistant Breast Cancer than Paclitaxel via Avoiding Efflux Transport
  • Xiaojie Zang
  • Guangji Wang
  • Qingyun Cai
  • Xiao Zheng
  • Jingwei Zhang
  • Qianying Chen
  • Baojin Wu
  • Xiong Zhu
  • Haiping Hao
  • Fang Zhou
Drug Metabolism and Disposition (2018) 46 (5): 542.
2,4,6-Substituted Quinazolines with Extraordinary Inhibitory Potency toward ABCG2
  • Michael K. Krapf
  • Jennifer Gallus
  • Vigneshwaran Namasivayam
  • Michael Wiese
Journal of Medicinal Chemistry (2018) 61 (17): 7952.
Pro-Angiogenic Effects of Low Dose Ethoxidine in a Murine Model of Ischemic Hindlimb: Correlation between Ethoxidine Levels and Increased Activation of the Nitric Oxide Pathway
  • Nicolas Clere
  • Kim Hung Thien To
  • Samuel Legeay
  • Samuel Bertrand
  • Jean Jacques Helesbeux
  • Olivier Duval
  • Sébastien Faure
Molecules (2017) 22 (4): 627.
Overcoming ABC transporter-mediated multidrug resistance: The dual role of tyrosine kinase inhibitors as multitargeting agents
  • Giovanni Luca Beretta
  • Giuliana Cassinelli
  • Marzia Pennati
  • Valentina Zuco
  • Laura Gatti
European Journal of Medicinal Chemistry (2017) 142: 271.
Renal Drug Transporters and Drug Interactions
  • Anton Ivanyuk
  • Françoise Livio
  • Jérôme Biollaz
  • Thierry Buclin
Clinical Pharmacokinetics (2017) 56 (8): 825.
Implications of ABCG2 Expression on Irinotecan Treatment of Colorectal Cancer Patients: A Review
  • Dorte Lisbet Nielsen
  • Jesper Palshof
  • Nils Brünner
  • Jan Stenvang
  • Birgitte Martine Viuff
International Journal of Molecular Sciences (2017) 18 (9): 1926.
The dopamine D 3 receptor antagonists PG01037, NGB2904, SB277011A, and U99194 reverse ABCG2 transporter-mediated drug resistance in cancer cell lines
  • Noor Hussein
  • Haneen Amawi
  • Chandrabose Karthikeyan
  • F. Scott Hall
  • Roopali Mittal
  • Piyush Trivedi
  • Charles R. Ashby
  • Amit K. Tiwari
Cancer Letters (2017) 396: 167.
Increased delivery of chemotherapy to the vitreous by inhibition of the blood-retinal barrier
  • Guillem Pascual-Pasto
  • Nagore G. Olaciregui
  • Javier A.W. Opezzo
  • Helena Castillo-Ecija
  • Maria Cuadrado-Vilanova
  • Sonia Paco
  • Ezequiel M. Rivero
  • Monica Vila-Ubach
  • Camilo A. Restrepo-Perdomo
  • Montserrat Torrebadell
  • Mariona Suñol
  • Paula Schaiquevich
  • Jaume Mora
  • Guillermo F. Bramuglia
  • Guillermo L. Chantada
  • Angel M. Carcaboso
Journal of Controlled Release (2017) 264: 34.
Imatinib Inhibits the Renewal and Tumorigenicity of CT-26 Colon Cancer Cells after Cytoreductive Treatment with Doxorubicin
  • Małgorzata Przybyszewska
  • Joanna Miłoszewska
  • Agnieszka Kotlarz
  • Paweł Swoboda
  • Kazimiera Pyśniak
  • Wojciech Szczepek
  • Łukasz Kaczmarek
  • Sergiusz Markowicz
Archivum Immunologiae et Therapiae Experimentalis (2017) 65 (1): 51.
The effects of dietary and herbal phytochemicals on drug transporters
  • Yan Li
  • Jezrael Revalde
  • James W. Paxton
Advanced Drug Delivery Reviews (2017) 116: 45.
ABCG2/BCRP: Specific and Nonspecific Modulators
  • Diana Peña-Solórzano
  • Simone Alexandra Stark
  • Burkhard König
  • Cesar Augusto Sierra
  • Cristian Ochoa-Puentes
Medicinal Research Reviews (2017) 37 (5): 987.
ABCG2 inhibition as a therapeutic approach for overcoming multidrug resistance in cancer
  • Maryam Hosseini Hasanabady
  • Fatemeh Kalalinia
Journal of Biosciences (2016) 41 (2): 313.
Impact of Membrane Drug Transporters on Resistance to Small-Molecule Tyrosine Kinase Inhibitors
  • Claudia Neul
  • Elke Schaeffeler
  • Alex Sparreboom
  • Stefan Laufer
  • Matthias Schwab
  • Anne T. Nies
Trends in Pharmacological Sciences (2016) 37 (11): 904.
Population Pharmacokinetic Analysis of the Oral Absorption Process and Explaining Intra-Subject Variability in Plasma Exposures of Imatinib in Healthy Volunteers
  • Ali-Akbar Golabchifar
  • Saeed Rezaee
  • Nahid Mobarghei Dinan
  • Abbas Kebriaeezadeh
  • Mohammad-Reza Rouini
European Journal of Drug Metabolism and Pharmacokinetics (2016) 41 (5): 527.
Molecular mechanisms of drug resistance and its reversal in cancer
  • Melis Kartal-Yandim
  • Aysun Adan-Gokbulut
  • Yusuf Baran
Critical Reviews in Biotechnology (2016) 36 (4): 716.
Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway
  • Ting Chen
  • Changyuan Wang
  • Qi Liu
  • Qiang Meng
  • Huijun Sun
  • Xiaokui Huo
  • Pengyuan Sun
  • Jinyong Peng
  • Zhihao Liu
  • Xiaobo Yang
  • Kexin Liu
Cancer Biology & Therapy (2015) 16 (1): 106.
Photochemical internalisation, a minimally invasive strategy for light-controlled endosomal escape of cancer stem cell-targeting therapeutics
  • Pål Kristian Selbo
  • Monica Bostad
  • Cathrine Elisabeth Olsen
  • Victoria Tudor Edwards
  • Anders Høgset
  • Anette Weyergang
  • Kristian Berg
Photochemical & Photobiological Sciences (2015) 14 (8): 1433.
High methotrexate exposure and toxicity in children with t(9;22) positive acute lymphoblastic leukaemia treated with imatinib
  • C. Loue
  • N. Garnier
  • Y. Bertrand
  • N. Bleyzac
Journal of Clinical Pharmacy and Therapeutics (2015) 40 (5): 599.
  • Online ISSN 1538-7445
  • Print ISSN 0008-5472

AACR Journals

 

 

  • Copyright © 2022 by the American Association for Cancer Research.
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept